Table 1.
Baseline characteristics of the study population
| Control group (n = 242) | PPI group (n = 834) | P | |
|---|---|---|---|
| Age (y) | 62.39±11.00 | 63.20±11.26 | 0.324 |
| Male sex | 166 (68.6%) | 528 (63.3%) | 0.130 |
| Diabetes mellitus | 81 (33.5%) | 268 (32.1%) | 0.696 |
| Underlying cardiac disease | 0.197 | ||
| Angina pectoris | 160 (66.1%) | 571 (68.5%) | |
| NSTEMI | 29 (12.0%) | 118 (14.1%) | |
| STEMI | 44 (18.2%) | 130 (15.6%) | |
| ICMP | 9 (3.7%) | 15 (1.8%) | |
| Serum magnesium (mg/dL) | 2.02±0.18 | 2.03±0.18 | 0.948 |
| Serum creatinine (mg/dL) | 0.86±0.34 | 0.84±0.30 | 0.415 |
| eGFR (mL/min/1.73 m2) | 88.62±20.02 | 88.26±19.66 | 0.801 |
| Serum albumin (g/dL) | 4.40±0.38 | 4.37±0.40 | 0.211 |
| Serum calcium (mg/dL) | 9.03±0.51 | 8.97±0.56 | 0.251 |
| Serum phosphate (mg/dL) | 3.35±0.80 | 3.37±0.76 | 0.841 |
| Serum potassium (mEq/L) | 4.17±0.48 | 4.16±0.44 | 0.925 |
| Use of diuretics during follow-up period | 76 (31.4%) | 218 (26.1%) | 0.106 |
Values are N, mean ± SD.
eGFR, estimated glomerular filtration rate; ICMP, ischemic cardiomyopathy; NSTEMI, non-ST elevation myocardial infarction; STEMI, ST elevation myocardial infarction.